Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remuzzi

Showing results (481-490 of 546) with videos related to

Pageof 55
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 20, 1998
Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritisC Zoja, M Abbate, D Corna, et al.
Journal of Lipid Research|December 1, 1989
Development of a mass spectrometric method to quantitate platelet activating factor in mouse urineE Benfenati, D Macconi, M Noris, et al.
Kidney International|July 1, 1993
Methylprednisolone normalizes superoxide anion production by polymorphs from patients with ANCA-positive vasculitidesD Macconi, A F Zanoli, S Orisio, et al.
The New England Journal of Medicine|June 19, 1980
Aspirin and thrombosis in patients undergoing hemodialysisG Remuzzi, D Marchesi, A Schieppati, et al.
Lancet (London, England)|August 7, 1999
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaP Ruggenenti, A Perna, G Gherardi, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic PurpuraM Noris, P Ruggenenti, A Perna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigensS Aiello, M Noris, G Piccinini, et al.
Lancet (London, England)|July 20, 1996
Health services: an Italian marketA del Favero, G Barro, G Vicari, et al.
Cell Transplantation|August 15, 2012
A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashionC Xinaris, M Morigi, V Benedetti, et al.
British Medical Journal (Clinical Research Ed.)|November 6, 1982
Haemolytic uraemic syndrome: therapeutic effect of plasma infusionR Misiani, A C Appiani, A Edefonti, et al.
Pageof 55

Showing results (481-490 of 546) with videos related to

Sort By:
Pageof 55
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 20, 1998
Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritisC Zoja, M Abbate, D Corna, et al.
Journal of Lipid Research|December 1, 1989
Development of a mass spectrometric method to quantitate platelet activating factor in mouse urineE Benfenati, D Macconi, M Noris, et al.
Kidney International|July 1, 1993
Methylprednisolone normalizes superoxide anion production by polymorphs from patients with ANCA-positive vasculitidesD Macconi, A F Zanoli, S Orisio, et al.
The New England Journal of Medicine|June 19, 1980
Aspirin and thrombosis in patients undergoing hemodialysisG Remuzzi, D Marchesi, A Schieppati, et al.
Lancet (London, England)|August 7, 1999
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaP Ruggenenti, A Perna, G Gherardi, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic PurpuraM Noris, P Ruggenenti, A Perna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigensS Aiello, M Noris, G Piccinini, et al.
Lancet (London, England)|July 20, 1996
Health services: an Italian marketA del Favero, G Barro, G Vicari, et al.
Cell Transplantation|August 15, 2012
A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashionC Xinaris, M Morigi, V Benedetti, et al.
British Medical Journal (Clinical Research Ed.)|November 6, 1982
Haemolytic uraemic syndrome: therapeutic effect of plasma infusionR Misiani, A C Appiani, A Edefonti, et al.
Pageof 55